Global Second-Generation Antipsychotics Market Research Report 2026(Status and Outlook)
Second-generation antipsychotics, also known as atypical antipsychotics or novel antipsychotics. Compared with the first generation drugs, the second generation antipsychotic drugs have significant differences in pharmacological mechanisms, clinical efficacy, and side effect profiles, making them the mainstream choice for the treatment of severe mental disorders such as schizophrenia and bipolar disorder. From the perspective of pharmacological mechanisms, second-generation antipsychotics can be divided into four categories: 5-hydroxytryptamine and dopamine receptor antagonists (such as risperidone, olanzapine, quetiapine, and ziprasidone), multi receptor acting drugs (such as clozapine), selective dopamine receptor antagonists (such as amisulpride), and dopamine receptor partial agonists (such as aripiprazole).
The global Second-Generation Antipsychotics market size was estimated at USD 45000.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 1.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Second-Generation Antipsychotics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Second-Generation Antipsychotics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Second-Generation Antipsychotics market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Second-Generation Antipsychotics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Second-Generation Antipsychotics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Second-Generation Antipsychotics market size was estimated at USD 45000.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 1.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Second-Generation Antipsychotics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Second-Generation Antipsychotics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Second-Generation Antipsychotics market.
Global Second-Generation Antipsychotics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Sumitomo Dainippon Pharma
- Roche
- Pfizer
- Novartis
- Otsuka Pharmaceutical
- AbbVie
- Johnson And Johnson
- Ipsen
- Merck
- Eli Lilly
- Luye Pharma Group
- Nhwa Pharmaceutical
- Livzon Pharmaceutical Group
- Qilu Pharmaceutical
- CSPC Pharmaceutical Group
- Chengdu Kanghong Pharmaceutical
- Hansoh Pharma
- Hisun Pharmaceutical
- Chia Tai Tianqing Pharmaceutical
- Yangtze River Pharmaceutical Group
Market Segmentation (by Type)
- 5-Hydroxytryptamine And Dopamine Receptor Antagonists
- Multi Receptor Acting Drugs
- Selective Dopamine Receptor Antagonists
- Dopamine Receptor Partial Agonists
Market Segmentation (by Application)
- Schizophrenia
- Bipolar Disorder
- Adjuvant Treatment For Depression
- Other Mental Illnesses
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Second-Generation Antipsychotics Market
Overview of the regional outlook of the Second-Generation Antipsychotics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Second-Generation Antipsychotics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Second-Generation Antipsychotics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Second-Generation Antipsychotics
1.2 Key Market Segments
1.2.1 Second-Generation Antipsychotics Segment by Type
1.2.2 Second-Generation Antipsychotics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SECOND-GENERATION ANTIPSYCHOTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Second-Generation Antipsychotics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Second-Generation Antipsychotics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SECOND-GENERATION ANTIPSYCHOTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Second-Generation Antipsychotics Product Life Cycle
3.3 Global Second-Generation Antipsychotics Sales by Manufacturers (2020-2025)
3.4 Global Second-Generation Antipsychotics Revenue Market Share by Manufacturers (2020-2025)
3.5 Second-Generation Antipsychotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Second-Generation Antipsychotics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Second-Generation Antipsychotics Market Competitive Situation and Trends
3.8.1 Second-Generation Antipsychotics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Second-Generation Antipsychotics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 SECOND-GENERATION ANTIPSYCHOTICS INDUSTRY CHAIN ANALYSIS
4.1 Second-Generation Antipsychotics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SECOND-GENERATION ANTIPSYCHOTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Second-Generation Antipsychotics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Second-Generation Antipsychotics Market
5.7 ESG Ratings of Leading Companies
6 SECOND-GENERATION ANTIPSYCHOTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Second-Generation Antipsychotics Sales Market Share by Type (2020-2025)
6.3 Global Second-Generation Antipsychotics Market Size by Type (2020-2025)
6.4 Global Second-Generation Antipsychotics Price by Type (2020-2025)
7 SECOND-GENERATION ANTIPSYCHOTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Second-Generation Antipsychotics Market Sales by Application (2020-2025)
7.3 Global Second-Generation Antipsychotics Market Size (M USD) by Application (2020-2025)
7.4 Global Second-Generation Antipsychotics Sales Growth Rate by Application (2020-2025)
8 SECOND-GENERATION ANTIPSYCHOTICS MARKET SALES BY REGION
8.1 Global Second-Generation Antipsychotics Sales by Region
8.1.1 Global Second-Generation Antipsychotics Sales by Region
8.1.2 Global Second-Generation Antipsychotics Sales Market Share by Region
8.2 Global Second-Generation Antipsychotics Market Size by Region
8.2.1 Global Second-Generation Antipsychotics Market Size by Region
8.2.2 Global Second-Generation Antipsychotics Market Size by Region
8.3 North America
8.3.1 North America Second-Generation Antipsychotics Sales by Country
8.3.2 North America Second-Generation Antipsychotics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Second-Generation Antipsychotics Sales by Country
8.4.2 Europe Second-Generation Antipsychotics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Second-Generation Antipsychotics Sales by Region
8.5.2 Asia Pacific Second-Generation Antipsychotics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Second-Generation Antipsychotics Sales by Country
8.6.2 South America Second-Generation Antipsychotics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Second-Generation Antipsychotics Sales by Region
8.7.2 Middle East and Africa Second-Generation Antipsychotics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 SECOND-GENERATION ANTIPSYCHOTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Second-Generation Antipsychotics by Region(2020-2025)
9.2 Global Second-Generation Antipsychotics Revenue Market Share by Region (2020-2025)
9.3 Global Second-Generation Antipsychotics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Second-Generation Antipsychotics Production
9.4.1 North America Second-Generation Antipsychotics Production Growth Rate (2020-2025)
9.4.2 North America Second-Generation Antipsychotics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Second-Generation Antipsychotics Production
9.5.1 Europe Second-Generation Antipsychotics Production Growth Rate (2020-2025)
9.5.2 Europe Second-Generation Antipsychotics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Second-Generation Antipsychotics Production (2020-2025)
9.6.1 Japan Second-Generation Antipsychotics Production Growth Rate (2020-2025)
9.6.2 Japan Second-Generation Antipsychotics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Second-Generation Antipsychotics Production (2020-2025)
9.7.1 China Second-Generation Antipsychotics Production Growth Rate (2020-2025)
9.7.2 China Second-Generation Antipsychotics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sumitomo Dainippon Pharma
10.1.1 Sumitomo Dainippon Pharma Basic Information
10.1.2 Sumitomo Dainippon Pharma Second-Generation Antipsychotics Product Overview
10.1.3 Sumitomo Dainippon Pharma Second-Generation Antipsychotics Product Market Performance
10.1.4 Sumitomo Dainippon Pharma Business Overview
10.1.5 Sumitomo Dainippon Pharma SWOT Analysis
10.1.6 Sumitomo Dainippon Pharma Recent Developments
10.2 Roche
10.2.1 Roche Basic Information
10.2.2 Roche Second-Generation Antipsychotics Product Overview
10.2.3 Roche Second-Generation Antipsychotics Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Pfizer
10.3.1 Pfizer Basic Information
10.3.2 Pfizer Second-Generation Antipsychotics Product Overview
10.3.3 Pfizer Second-Generation Antipsychotics Product Market Performance
10.3.4 Pfizer Business Overview
10.3.5 Pfizer SWOT Analysis
10.3.6 Pfizer Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis Second-Generation Antipsychotics Product Overview
10.4.3 Novartis Second-Generation Antipsychotics Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Otsuka Pharmaceutical
10.5.1 Otsuka Pharmaceutical Basic Information
10.5.2 Otsuka Pharmaceutical Second-Generation Antipsychotics Product Overview
10.5.3 Otsuka Pharmaceutical Second-Generation Antipsychotics Product Market Performance
10.5.4 Otsuka Pharmaceutical Business Overview
10.5.5 Otsuka Pharmaceutical Recent Developments
10.6 AbbVie
10.6.1 AbbVie Basic Information
10.6.2 AbbVie Second-Generation Antipsychotics Product Overview
10.6.3 AbbVie Second-Generation Antipsychotics Product Market Performance
10.6.4 AbbVie Business Overview
10.6.5 AbbVie Recent Developments
10.7 Johnson And Johnson
10.7.1 Johnson And Johnson Basic Information
10.7.2 Johnson And Johnson Second-Generation Antipsychotics Product Overview
10.7.3 Johnson And Johnson Second-Generation Antipsychotics Product Market Performance
10.7.4 Johnson And Johnson Business Overview
10.7.5 Johnson And Johnson Recent Developments
10.8 Ipsen
10.8.1 Ipsen Basic Information
10.8.2 Ipsen Second-Generation Antipsychotics Product Overview
10.8.3 Ipsen Second-Generation Antipsychotics Product Market Performance
10.8.4 Ipsen Business Overview
10.8.5 Ipsen Recent Developments
10.9 Merck
10.9.1 Merck Basic Information
10.9.2 Merck Second-Generation Antipsychotics Product Overview
10.9.3 Merck Second-Generation Antipsychotics Product Market Performance
10.9.4 Merck Business Overview
10.9.5 Merck Recent Developments
10.10 Eli Lilly
10.10.1 Eli Lilly Basic Information
10.10.2 Eli Lilly Second-Generation Antipsychotics Product Overview
10.10.3 Eli Lilly Second-Generation Antipsychotics Product Market Performance
10.10.4 Eli Lilly Business Overview
10.10.5 Eli Lilly Recent Developments
10.11 Luye Pharma Group
10.11.1 Luye Pharma Group Basic Information
10.11.2 Luye Pharma Group Second-Generation Antipsychotics Product Overview
10.11.3 Luye Pharma Group Second-Generation Antipsychotics Product Market Performance
10.11.4 Luye Pharma Group Business Overview
10.11.5 Luye Pharma Group Recent Developments
10.12 Nhwa Pharmaceutical
10.12.1 Nhwa Pharmaceutical Basic Information
10.12.2 Nhwa Pharmaceutical Second-Generation Antipsychotics Product Overview
10.12.3 Nhwa Pharmaceutical Second-Generation Antipsychotics Product Market Performance
10.12.4 Nhwa Pharmaceutical Business Overview
10.12.5 Nhwa Pharmaceutical Recent Developments
10.13 Livzon Pharmaceutical Group
10.13.1 Livzon Pharmaceutical Group Basic Information
10.13.2 Livzon Pharmaceutical Group Second-Generation Antipsychotics Product Overview
10.13.3 Livzon Pharmaceutical Group Second-Generation Antipsychotics Product Market Performance
10.13.4 Livzon Pharmaceutical Group Business Overview
10.13.5 Livzon Pharmaceutical Group Recent Developments
10.14 Qilu Pharmaceutical
10.14.1 Qilu Pharmaceutical Basic Information
10.14.2 Qilu Pharmaceutical Second-Generation Antipsychotics Product Overview
10.14.3 Qilu Pharmaceutical Second-Generation Antipsychotics Product Market Performance
10.14.4 Qilu Pharmaceutical Business Overview
10.14.5 Qilu Pharmaceutical Recent Developments
10.15 CSPC Pharmaceutical Group
10.15.1 CSPC Pharmaceutical Group Basic Information
10.15.2 CSPC Pharmaceutical Group Second-Generation Antipsychotics Product Overview
10.15.3 CSPC Pharmaceutical Group Second-Generation Antipsychotics Product Market Performance
10.15.4 CSPC Pharmaceutical Group Business Overview
10.15.5 CSPC Pharmaceutical Group Recent Developments
10.16 Chengdu Kanghong Pharmaceutical
10.16.1 Chengdu Kanghong Pharmaceutical Basic Information
10.16.2 Chengdu Kanghong Pharmaceutical Second-Generation Antipsychotics Product Overview
10.16.3 Chengdu Kanghong Pharmaceutical Second-Generation Antipsychotics Product Market Performance
10.16.4 Chengdu Kanghong Pharmaceutical Business Overview
10.16.5 Chengdu Kanghong Pharmaceutical Recent Developments
10.17 Hansoh Pharma
10.17.1 Hansoh Pharma Basic Information
10.17.2 Hansoh Pharma Second-Generation Antipsychotics Product Overview
10.17.3 Hansoh Pharma Second-Generation Antipsychotics Product Market Performance
10.17.4 Hansoh Pharma Business Overview
10.17.5 Hansoh Pharma Recent Developments
10.18 Hisun Pharmaceutical
10.18.1 Hisun Pharmaceutical Basic Information
10.18.2 Hisun Pharmaceutical Second-Generation Antipsychotics Product Overview
10.18.3 Hisun Pharmaceutical Second-Generation Antipsychotics Product Market Performance
10.18.4 Hisun Pharmaceutical Business Overview
10.18.5 Hisun Pharmaceutical Recent Developments
10.19 Chia Tai Tianqing Pharmaceutical
10.19.1 Chia Tai Tianqing Pharmaceutical Basic Information
10.19.2 Chia Tai Tianqing Pharmaceutical Second-Generation Antipsychotics Product Overview
10.19.3 Chia Tai Tianqing Pharmaceutical Second-Generation Antipsychotics Product Market Performance
10.19.4 Chia Tai Tianqing Pharmaceutical Business Overview
10.19.5 Chia Tai Tianqing Pharmaceutical Recent Developments
10.20 Yangtze River Pharmaceutical Group
10.20.1 Yangtze River Pharmaceutical Group Basic Information
10.20.2 Yangtze River Pharmaceutical Group Second-Generation Antipsychotics Product Overview
10.20.3 Yangtze River Pharmaceutical Group Second-Generation Antipsychotics Product Market Performance
10.20.4 Yangtze River Pharmaceutical Group Business Overview
10.20.5 Yangtze River Pharmaceutical Group Recent Developments
11 SECOND-GENERATION ANTIPSYCHOTICS MARKET FORECAST BY REGION
11.1 Global Second-Generation Antipsychotics Market Size Forecast
11.2 Global Second-Generation Antipsychotics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Second-Generation Antipsychotics Market Size Forecast by Country
11.2.3 Asia Pacific Second-Generation Antipsychotics Market Size Forecast by Region
11.2.4 South America Second-Generation Antipsychotics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Second-Generation Antipsychotics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Second-Generation Antipsychotics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Second-Generation Antipsychotics by Type (2026-2035)
12.1.2 Global Second-Generation Antipsychotics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Second-Generation Antipsychotics by Type (2026-2035)
12.2 Global Second-Generation Antipsychotics Market Forecast by Application (2026-2035)
12.2.1 Global Second-Generation Antipsychotics Sales (K MT) Forecast by Application
12.2.2 Global Second-Generation Antipsychotics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Second-Generation Antipsychotics
1.2 Key Market Segments
1.2.1 Second-Generation Antipsychotics Segment by Type
1.2.2 Second-Generation Antipsychotics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SECOND-GENERATION ANTIPSYCHOTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Second-Generation Antipsychotics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Second-Generation Antipsychotics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SECOND-GENERATION ANTIPSYCHOTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Second-Generation Antipsychotics Product Life Cycle
3.3 Global Second-Generation Antipsychotics Sales by Manufacturers (2020-2025)
3.4 Global Second-Generation Antipsychotics Revenue Market Share by Manufacturers (2020-2025)
3.5 Second-Generation Antipsychotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Second-Generation Antipsychotics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Second-Generation Antipsychotics Market Competitive Situation and Trends
3.8.1 Second-Generation Antipsychotics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Second-Generation Antipsychotics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 SECOND-GENERATION ANTIPSYCHOTICS INDUSTRY CHAIN ANALYSIS
4.1 Second-Generation Antipsychotics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SECOND-GENERATION ANTIPSYCHOTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Second-Generation Antipsychotics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Second-Generation Antipsychotics Market
5.7 ESG Ratings of Leading Companies
6 SECOND-GENERATION ANTIPSYCHOTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Second-Generation Antipsychotics Sales Market Share by Type (2020-2025)
6.3 Global Second-Generation Antipsychotics Market Size by Type (2020-2025)
6.4 Global Second-Generation Antipsychotics Price by Type (2020-2025)
7 SECOND-GENERATION ANTIPSYCHOTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Second-Generation Antipsychotics Market Sales by Application (2020-2025)
7.3 Global Second-Generation Antipsychotics Market Size (M USD) by Application (2020-2025)
7.4 Global Second-Generation Antipsychotics Sales Growth Rate by Application (2020-2025)
8 SECOND-GENERATION ANTIPSYCHOTICS MARKET SALES BY REGION
8.1 Global Second-Generation Antipsychotics Sales by Region
8.1.1 Global Second-Generation Antipsychotics Sales by Region
8.1.2 Global Second-Generation Antipsychotics Sales Market Share by Region
8.2 Global Second-Generation Antipsychotics Market Size by Region
8.2.1 Global Second-Generation Antipsychotics Market Size by Region
8.2.2 Global Second-Generation Antipsychotics Market Size by Region
8.3 North America
8.3.1 North America Second-Generation Antipsychotics Sales by Country
8.3.2 North America Second-Generation Antipsychotics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Second-Generation Antipsychotics Sales by Country
8.4.2 Europe Second-Generation Antipsychotics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Second-Generation Antipsychotics Sales by Region
8.5.2 Asia Pacific Second-Generation Antipsychotics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Second-Generation Antipsychotics Sales by Country
8.6.2 South America Second-Generation Antipsychotics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Second-Generation Antipsychotics Sales by Region
8.7.2 Middle East and Africa Second-Generation Antipsychotics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 SECOND-GENERATION ANTIPSYCHOTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Second-Generation Antipsychotics by Region(2020-2025)
9.2 Global Second-Generation Antipsychotics Revenue Market Share by Region (2020-2025)
9.3 Global Second-Generation Antipsychotics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Second-Generation Antipsychotics Production
9.4.1 North America Second-Generation Antipsychotics Production Growth Rate (2020-2025)
9.4.2 North America Second-Generation Antipsychotics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Second-Generation Antipsychotics Production
9.5.1 Europe Second-Generation Antipsychotics Production Growth Rate (2020-2025)
9.5.2 Europe Second-Generation Antipsychotics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Second-Generation Antipsychotics Production (2020-2025)
9.6.1 Japan Second-Generation Antipsychotics Production Growth Rate (2020-2025)
9.6.2 Japan Second-Generation Antipsychotics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Second-Generation Antipsychotics Production (2020-2025)
9.7.1 China Second-Generation Antipsychotics Production Growth Rate (2020-2025)
9.7.2 China Second-Generation Antipsychotics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sumitomo Dainippon Pharma
10.1.1 Sumitomo Dainippon Pharma Basic Information
10.1.2 Sumitomo Dainippon Pharma Second-Generation Antipsychotics Product Overview
10.1.3 Sumitomo Dainippon Pharma Second-Generation Antipsychotics Product Market Performance
10.1.4 Sumitomo Dainippon Pharma Business Overview
10.1.5 Sumitomo Dainippon Pharma SWOT Analysis
10.1.6 Sumitomo Dainippon Pharma Recent Developments
10.2 Roche
10.2.1 Roche Basic Information
10.2.2 Roche Second-Generation Antipsychotics Product Overview
10.2.3 Roche Second-Generation Antipsychotics Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Pfizer
10.3.1 Pfizer Basic Information
10.3.2 Pfizer Second-Generation Antipsychotics Product Overview
10.3.3 Pfizer Second-Generation Antipsychotics Product Market Performance
10.3.4 Pfizer Business Overview
10.3.5 Pfizer SWOT Analysis
10.3.6 Pfizer Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis Second-Generation Antipsychotics Product Overview
10.4.3 Novartis Second-Generation Antipsychotics Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Otsuka Pharmaceutical
10.5.1 Otsuka Pharmaceutical Basic Information
10.5.2 Otsuka Pharmaceutical Second-Generation Antipsychotics Product Overview
10.5.3 Otsuka Pharmaceutical Second-Generation Antipsychotics Product Market Performance
10.5.4 Otsuka Pharmaceutical Business Overview
10.5.5 Otsuka Pharmaceutical Recent Developments
10.6 AbbVie
10.6.1 AbbVie Basic Information
10.6.2 AbbVie Second-Generation Antipsychotics Product Overview
10.6.3 AbbVie Second-Generation Antipsychotics Product Market Performance
10.6.4 AbbVie Business Overview
10.6.5 AbbVie Recent Developments
10.7 Johnson And Johnson
10.7.1 Johnson And Johnson Basic Information
10.7.2 Johnson And Johnson Second-Generation Antipsychotics Product Overview
10.7.3 Johnson And Johnson Second-Generation Antipsychotics Product Market Performance
10.7.4 Johnson And Johnson Business Overview
10.7.5 Johnson And Johnson Recent Developments
10.8 Ipsen
10.8.1 Ipsen Basic Information
10.8.2 Ipsen Second-Generation Antipsychotics Product Overview
10.8.3 Ipsen Second-Generation Antipsychotics Product Market Performance
10.8.4 Ipsen Business Overview
10.8.5 Ipsen Recent Developments
10.9 Merck
10.9.1 Merck Basic Information
10.9.2 Merck Second-Generation Antipsychotics Product Overview
10.9.3 Merck Second-Generation Antipsychotics Product Market Performance
10.9.4 Merck Business Overview
10.9.5 Merck Recent Developments
10.10 Eli Lilly
10.10.1 Eli Lilly Basic Information
10.10.2 Eli Lilly Second-Generation Antipsychotics Product Overview
10.10.3 Eli Lilly Second-Generation Antipsychotics Product Market Performance
10.10.4 Eli Lilly Business Overview
10.10.5 Eli Lilly Recent Developments
10.11 Luye Pharma Group
10.11.1 Luye Pharma Group Basic Information
10.11.2 Luye Pharma Group Second-Generation Antipsychotics Product Overview
10.11.3 Luye Pharma Group Second-Generation Antipsychotics Product Market Performance
10.11.4 Luye Pharma Group Business Overview
10.11.5 Luye Pharma Group Recent Developments
10.12 Nhwa Pharmaceutical
10.12.1 Nhwa Pharmaceutical Basic Information
10.12.2 Nhwa Pharmaceutical Second-Generation Antipsychotics Product Overview
10.12.3 Nhwa Pharmaceutical Second-Generation Antipsychotics Product Market Performance
10.12.4 Nhwa Pharmaceutical Business Overview
10.12.5 Nhwa Pharmaceutical Recent Developments
10.13 Livzon Pharmaceutical Group
10.13.1 Livzon Pharmaceutical Group Basic Information
10.13.2 Livzon Pharmaceutical Group Second-Generation Antipsychotics Product Overview
10.13.3 Livzon Pharmaceutical Group Second-Generation Antipsychotics Product Market Performance
10.13.4 Livzon Pharmaceutical Group Business Overview
10.13.5 Livzon Pharmaceutical Group Recent Developments
10.14 Qilu Pharmaceutical
10.14.1 Qilu Pharmaceutical Basic Information
10.14.2 Qilu Pharmaceutical Second-Generation Antipsychotics Product Overview
10.14.3 Qilu Pharmaceutical Second-Generation Antipsychotics Product Market Performance
10.14.4 Qilu Pharmaceutical Business Overview
10.14.5 Qilu Pharmaceutical Recent Developments
10.15 CSPC Pharmaceutical Group
10.15.1 CSPC Pharmaceutical Group Basic Information
10.15.2 CSPC Pharmaceutical Group Second-Generation Antipsychotics Product Overview
10.15.3 CSPC Pharmaceutical Group Second-Generation Antipsychotics Product Market Performance
10.15.4 CSPC Pharmaceutical Group Business Overview
10.15.5 CSPC Pharmaceutical Group Recent Developments
10.16 Chengdu Kanghong Pharmaceutical
10.16.1 Chengdu Kanghong Pharmaceutical Basic Information
10.16.2 Chengdu Kanghong Pharmaceutical Second-Generation Antipsychotics Product Overview
10.16.3 Chengdu Kanghong Pharmaceutical Second-Generation Antipsychotics Product Market Performance
10.16.4 Chengdu Kanghong Pharmaceutical Business Overview
10.16.5 Chengdu Kanghong Pharmaceutical Recent Developments
10.17 Hansoh Pharma
10.17.1 Hansoh Pharma Basic Information
10.17.2 Hansoh Pharma Second-Generation Antipsychotics Product Overview
10.17.3 Hansoh Pharma Second-Generation Antipsychotics Product Market Performance
10.17.4 Hansoh Pharma Business Overview
10.17.5 Hansoh Pharma Recent Developments
10.18 Hisun Pharmaceutical
10.18.1 Hisun Pharmaceutical Basic Information
10.18.2 Hisun Pharmaceutical Second-Generation Antipsychotics Product Overview
10.18.3 Hisun Pharmaceutical Second-Generation Antipsychotics Product Market Performance
10.18.4 Hisun Pharmaceutical Business Overview
10.18.5 Hisun Pharmaceutical Recent Developments
10.19 Chia Tai Tianqing Pharmaceutical
10.19.1 Chia Tai Tianqing Pharmaceutical Basic Information
10.19.2 Chia Tai Tianqing Pharmaceutical Second-Generation Antipsychotics Product Overview
10.19.3 Chia Tai Tianqing Pharmaceutical Second-Generation Antipsychotics Product Market Performance
10.19.4 Chia Tai Tianqing Pharmaceutical Business Overview
10.19.5 Chia Tai Tianqing Pharmaceutical Recent Developments
10.20 Yangtze River Pharmaceutical Group
10.20.1 Yangtze River Pharmaceutical Group Basic Information
10.20.2 Yangtze River Pharmaceutical Group Second-Generation Antipsychotics Product Overview
10.20.3 Yangtze River Pharmaceutical Group Second-Generation Antipsychotics Product Market Performance
10.20.4 Yangtze River Pharmaceutical Group Business Overview
10.20.5 Yangtze River Pharmaceutical Group Recent Developments
11 SECOND-GENERATION ANTIPSYCHOTICS MARKET FORECAST BY REGION
11.1 Global Second-Generation Antipsychotics Market Size Forecast
11.2 Global Second-Generation Antipsychotics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Second-Generation Antipsychotics Market Size Forecast by Country
11.2.3 Asia Pacific Second-Generation Antipsychotics Market Size Forecast by Region
11.2.4 South America Second-Generation Antipsychotics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Second-Generation Antipsychotics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Second-Generation Antipsychotics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Second-Generation Antipsychotics by Type (2026-2035)
12.1.2 Global Second-Generation Antipsychotics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Second-Generation Antipsychotics by Type (2026-2035)
12.2 Global Second-Generation Antipsychotics Market Forecast by Application (2026-2035)
12.2.1 Global Second-Generation Antipsychotics Sales (K MT) Forecast by Application
12.2.2 Global Second-Generation Antipsychotics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Second-Generation Antipsychotics Market Size by Type (M USD)
Table 4. Global Second-Generation Antipsychotics Market Size by Application
Table 5. Second-Generation Antipsychotics Market Size Comparison by Region (M USD)
Table 6. Global Second-Generation Antipsychotics Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Second-Generation Antipsychotics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Second-Generation Antipsychotics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Second-Generation Antipsychotics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Second-Generation Antipsychotics as of 2025)
Table 11. Global Market Second-Generation Antipsychotics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Second-Generation Antipsychotics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Second-Generation Antipsychotics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Second-Generation Antipsychotics Sales by Type (K MT)
Table 27. Global Second-Generation Antipsychotics Market Size by Type (M USD)
Table 28. Global Second-Generation Antipsychotics Sales (K MT) by Type (2020-2025)
Table 29. Global Second-Generation Antipsychotics Sales Market Share by Type (2020-2025)
Table 30. Global Second-Generation Antipsychotics Market Size (M USD) by Type (2020-2025)
Table 31. Global Second-Generation Antipsychotics Market Share by Type (2020-2025)
Table 32. Global Second-Generation Antipsychotics Price (USD/KG) by Type (2020-2025)
Table 33. Global Second-Generation Antipsychotics Sales (K MT) by Application
Table 34. Global Second-Generation Antipsychotics Market Size by Application
Table 35. Global Second-Generation Antipsychotics Sales by Application (2020-2025) & (K MT)
Table 36. Global Second-Generation Antipsychotics Sales Market Share by Application (2020-2025)
Table 37. Global Second-Generation Antipsychotics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Second-Generation Antipsychotics Market Share by Application (2020-2025)
Table 39. Global Second-Generation Antipsychotics Sales Growth Rate by Application (2020-2025)
Table 40. Global Second-Generation Antipsychotics Sales by Region (2020-2025) & (K MT)
Table 41. Global Second-Generation Antipsychotics Sales Market Share by Region (2020-2025)
Table 42. Global Second-Generation Antipsychotics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Second-Generation Antipsychotics Market Size by Region (2020-2025)
Table 44. North America Second-Generation Antipsychotics Sales by Country (2020-2025) & (K MT)
Table 45. North America Second-Generation Antipsychotics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Second-Generation Antipsychotics Sales by Country (2020-2025) & (K MT)
Table 47. Europe Second-Generation Antipsychotics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Second-Generation Antipsychotics Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Second-Generation Antipsychotics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Second-Generation Antipsychotics Sales by Country (2020-2025) & (K MT)
Table 51. South America Second-Generation Antipsychotics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Second-Generation Antipsychotics Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Second-Generation Antipsychotics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Second-Generation Antipsychotics Production (K MT) by Region(2020-2025)
Table 55. Global Second-Generation Antipsychotics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Second-Generation Antipsychotics Revenue Market Share by Region (2020-2025)
Table 57. Global Second-Generation Antipsychotics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Second-Generation Antipsychotics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Second-Generation Antipsychotics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Second-Generation Antipsychotics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Second-Generation Antipsychotics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sumitomo Dainippon Pharma Basic Information
Table 63. Sumitomo Dainippon Pharma Second-Generation Antipsychotics Product Overview
Table 64. Sumitomo Dainippon Pharma Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sumitomo Dainippon Pharma Business Overview
Table 66. Sumitomo Dainippon Pharma SWOT Analysis
Table 67. Sumitomo Dainippon Pharma Recent Developments
Table 68. Roche Basic Information
Table 69. Roche Second-Generation Antipsychotics Product Overview
Table 70. Roche Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Roche Business Overview
Table 72. Roche SWOT Analysis
Table 73. Roche Recent Developments
Table 74. Pfizer Basic Information
Table 75. Pfizer Second-Generation Antipsychotics Product Overview
Table 76. Pfizer Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Pfizer Business Overview
Table 78. Pfizer SWOT Analysis
Table 79. Pfizer Recent Developments
Table 80. Novartis Basic Information
Table 81. Novartis Second-Generation Antipsychotics Product Overview
Table 82. Novartis Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Novartis Business Overview
Table 84. Novartis Recent Developments
Table 85. Otsuka Pharmaceutical Basic Information
Table 86. Otsuka Pharmaceutical Second-Generation Antipsychotics Product Overview
Table 87. Otsuka Pharmaceutical Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Otsuka Pharmaceutical Business Overview
Table 89. Otsuka Pharmaceutical Recent Developments
Table 90. AbbVie Basic Information
Table 91. AbbVie Second-Generation Antipsychotics Product Overview
Table 92. AbbVie Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. AbbVie Business Overview
Table 94. AbbVie Recent Developments
Table 95. Johnson And Johnson Basic Information
Table 96. Johnson And Johnson Second-Generation Antipsychotics Product Overview
Table 97. Johnson And Johnson Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Johnson And Johnson Business Overview
Table 99. Johnson And Johnson Recent Developments
Table 100. Ipsen Basic Information
Table 101. Ipsen Second-Generation Antipsychotics Product Overview
Table 102. Ipsen Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Ipsen Business Overview
Table 104. Ipsen Recent Developments
Table 105. Merck Basic Information
Table 106. Merck Second-Generation Antipsychotics Product Overview
Table 107. Merck Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Merck Business Overview
Table 109. Merck Recent Developments
Table 110. Eli Lilly Basic Information
Table 111. Eli Lilly Second-Generation Antipsychotics Product Overview
Table 112. Eli Lilly Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Eli Lilly Business Overview
Table 114. Eli Lilly Recent Developments
Table 115. Luye Pharma Group Basic Information
Table 116. Luye Pharma Group Second-Generation Antipsychotics Product Overview
Table 117. Luye Pharma Group Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Luye Pharma Group Business Overview
Table 119. Luye Pharma Group Recent Developments
Table 120. Nhwa Pharmaceutical Basic Information
Table 121. Nhwa Pharmaceutical Second-Generation Antipsychotics Product Overview
Table 122. Nhwa Pharmaceutical Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Nhwa Pharmaceutical Business Overview
Table 124. Nhwa Pharmaceutical Recent Developments
Table 125. Livzon Pharmaceutical Group Basic Information
Table 126. Livzon Pharmaceutical Group Second-Generation Antipsychotics Product Overview
Table 127. Livzon Pharmaceutical Group Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Livzon Pharmaceutical Group Business Overview
Table 129. Livzon Pharmaceutical Group Recent Developments
Table 130. Qilu Pharmaceutical Basic Information
Table 131. Qilu Pharmaceutical Second-Generation Antipsychotics Product Overview
Table 132. Qilu Pharmaceutical Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Qilu Pharmaceutical Business Overview
Table 134. Qilu Pharmaceutical Recent Developments
Table 135. CSPC Pharmaceutical Group Basic Information
Table 136. CSPC Pharmaceutical Group Second-Generation Antipsychotics Product Overview
Table 137. CSPC Pharmaceutical Group Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. CSPC Pharmaceutical Group Business Overview
Table 139. CSPC Pharmaceutical Group Recent Developments
Table 140. Chengdu Kanghong Pharmaceutical Basic Information
Table 141. Chengdu Kanghong Pharmaceutical Second-Generation Antipsychotics Product Overview
Table 142. Chengdu Kanghong Pharmaceutical Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Chengdu Kanghong Pharmaceutical Business Overview
Table 144. Chengdu Kanghong Pharmaceutical Recent Developments
Table 145. Hansoh Pharma Basic Information
Table 146. Hansoh Pharma Second-Generation Antipsychotics Product Overview
Table 147. Hansoh Pharma Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Hansoh Pharma Business Overview
Table 149. Hansoh Pharma Recent Developments
Table 150. Hisun Pharmaceutical Basic Information
Table 151. Hisun Pharmaceutical Second-Generation Antipsychotics Product Overview
Table 152. Hisun Pharmaceutical Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Hisun Pharmaceutical Business Overview
Table 154. Hisun Pharmaceutical Recent Developments
Table 155. Chia Tai Tianqing Pharmaceutical Basic Information
Table 156. Chia Tai Tianqing Pharmaceutical Second-Generation Antipsychotics Product Overview
Table 157. Chia Tai Tianqing Pharmaceutical Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Chia Tai Tianqing Pharmaceutical Business Overview
Table 159. Chia Tai Tianqing Pharmaceutical Recent Developments
Table 160. Yangtze River Pharmaceutical Group Basic Information
Table 161. Yangtze River Pharmaceutical Group Second-Generation Antipsychotics Product Overview
Table 162. Yangtze River Pharmaceutical Group Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Yangtze River Pharmaceutical Group Business Overview
Table 164. Yangtze River Pharmaceutical Group Recent Developments
Table 165. Global Second-Generation Antipsychotics Sales Forecast by Region (2026-2035) & (K MT)
Table 166. Global Second-Generation Antipsychotics Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Second-Generation Antipsychotics Sales Forecast by Country (2026-2035) & (K MT)
Table 168. North America Second-Generation Antipsychotics Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Second-Generation Antipsychotics Sales Forecast by Country (2026-2035) & (K MT)
Table 170. Europe Second-Generation Antipsychotics Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Second-Generation Antipsychotics Sales Forecast by Region (2026-2035) & (K MT)
Table 172. Asia Pacific Second-Generation Antipsychotics Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Second-Generation Antipsychotics Sales Forecast by Country (2026-2035) & (K MT)
Table 174. South America Second-Generation Antipsychotics Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Second-Generation Antipsychotics Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Second-Generation Antipsychotics Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Second-Generation Antipsychotics Sales Forecast by Type (2026-2035) & (K MT)
Table 178. Global Second-Generation Antipsychotics Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Second-Generation Antipsychotics Price Forecast by Type (2026-2035) & (USD/KG)
Table 180. Global Second-Generation Antipsychotics Sales (K MT) Forecast by Application (2026-2035)
Table 181. Global Second-Generation Antipsychotics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Second-Generation Antipsychotics Market Size by Type (M USD)
Table 4. Global Second-Generation Antipsychotics Market Size by Application
Table 5. Second-Generation Antipsychotics Market Size Comparison by Region (M USD)
Table 6. Global Second-Generation Antipsychotics Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Second-Generation Antipsychotics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Second-Generation Antipsychotics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Second-Generation Antipsychotics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Second-Generation Antipsychotics as of 2025)
Table 11. Global Market Second-Generation Antipsychotics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Second-Generation Antipsychotics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Second-Generation Antipsychotics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Second-Generation Antipsychotics Sales by Type (K MT)
Table 27. Global Second-Generation Antipsychotics Market Size by Type (M USD)
Table 28. Global Second-Generation Antipsychotics Sales (K MT) by Type (2020-2025)
Table 29. Global Second-Generation Antipsychotics Sales Market Share by Type (2020-2025)
Table 30. Global Second-Generation Antipsychotics Market Size (M USD) by Type (2020-2025)
Table 31. Global Second-Generation Antipsychotics Market Share by Type (2020-2025)
Table 32. Global Second-Generation Antipsychotics Price (USD/KG) by Type (2020-2025)
Table 33. Global Second-Generation Antipsychotics Sales (K MT) by Application
Table 34. Global Second-Generation Antipsychotics Market Size by Application
Table 35. Global Second-Generation Antipsychotics Sales by Application (2020-2025) & (K MT)
Table 36. Global Second-Generation Antipsychotics Sales Market Share by Application (2020-2025)
Table 37. Global Second-Generation Antipsychotics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Second-Generation Antipsychotics Market Share by Application (2020-2025)
Table 39. Global Second-Generation Antipsychotics Sales Growth Rate by Application (2020-2025)
Table 40. Global Second-Generation Antipsychotics Sales by Region (2020-2025) & (K MT)
Table 41. Global Second-Generation Antipsychotics Sales Market Share by Region (2020-2025)
Table 42. Global Second-Generation Antipsychotics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Second-Generation Antipsychotics Market Size by Region (2020-2025)
Table 44. North America Second-Generation Antipsychotics Sales by Country (2020-2025) & (K MT)
Table 45. North America Second-Generation Antipsychotics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Second-Generation Antipsychotics Sales by Country (2020-2025) & (K MT)
Table 47. Europe Second-Generation Antipsychotics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Second-Generation Antipsychotics Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Second-Generation Antipsychotics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Second-Generation Antipsychotics Sales by Country (2020-2025) & (K MT)
Table 51. South America Second-Generation Antipsychotics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Second-Generation Antipsychotics Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Second-Generation Antipsychotics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Second-Generation Antipsychotics Production (K MT) by Region(2020-2025)
Table 55. Global Second-Generation Antipsychotics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Second-Generation Antipsychotics Revenue Market Share by Region (2020-2025)
Table 57. Global Second-Generation Antipsychotics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Second-Generation Antipsychotics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Second-Generation Antipsychotics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Second-Generation Antipsychotics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Second-Generation Antipsychotics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sumitomo Dainippon Pharma Basic Information
Table 63. Sumitomo Dainippon Pharma Second-Generation Antipsychotics Product Overview
Table 64. Sumitomo Dainippon Pharma Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sumitomo Dainippon Pharma Business Overview
Table 66. Sumitomo Dainippon Pharma SWOT Analysis
Table 67. Sumitomo Dainippon Pharma Recent Developments
Table 68. Roche Basic Information
Table 69. Roche Second-Generation Antipsychotics Product Overview
Table 70. Roche Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Roche Business Overview
Table 72. Roche SWOT Analysis
Table 73. Roche Recent Developments
Table 74. Pfizer Basic Information
Table 75. Pfizer Second-Generation Antipsychotics Product Overview
Table 76. Pfizer Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Pfizer Business Overview
Table 78. Pfizer SWOT Analysis
Table 79. Pfizer Recent Developments
Table 80. Novartis Basic Information
Table 81. Novartis Second-Generation Antipsychotics Product Overview
Table 82. Novartis Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Novartis Business Overview
Table 84. Novartis Recent Developments
Table 85. Otsuka Pharmaceutical Basic Information
Table 86. Otsuka Pharmaceutical Second-Generation Antipsychotics Product Overview
Table 87. Otsuka Pharmaceutical Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Otsuka Pharmaceutical Business Overview
Table 89. Otsuka Pharmaceutical Recent Developments
Table 90. AbbVie Basic Information
Table 91. AbbVie Second-Generation Antipsychotics Product Overview
Table 92. AbbVie Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. AbbVie Business Overview
Table 94. AbbVie Recent Developments
Table 95. Johnson And Johnson Basic Information
Table 96. Johnson And Johnson Second-Generation Antipsychotics Product Overview
Table 97. Johnson And Johnson Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Johnson And Johnson Business Overview
Table 99. Johnson And Johnson Recent Developments
Table 100. Ipsen Basic Information
Table 101. Ipsen Second-Generation Antipsychotics Product Overview
Table 102. Ipsen Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Ipsen Business Overview
Table 104. Ipsen Recent Developments
Table 105. Merck Basic Information
Table 106. Merck Second-Generation Antipsychotics Product Overview
Table 107. Merck Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Merck Business Overview
Table 109. Merck Recent Developments
Table 110. Eli Lilly Basic Information
Table 111. Eli Lilly Second-Generation Antipsychotics Product Overview
Table 112. Eli Lilly Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Eli Lilly Business Overview
Table 114. Eli Lilly Recent Developments
Table 115. Luye Pharma Group Basic Information
Table 116. Luye Pharma Group Second-Generation Antipsychotics Product Overview
Table 117. Luye Pharma Group Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Luye Pharma Group Business Overview
Table 119. Luye Pharma Group Recent Developments
Table 120. Nhwa Pharmaceutical Basic Information
Table 121. Nhwa Pharmaceutical Second-Generation Antipsychotics Product Overview
Table 122. Nhwa Pharmaceutical Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Nhwa Pharmaceutical Business Overview
Table 124. Nhwa Pharmaceutical Recent Developments
Table 125. Livzon Pharmaceutical Group Basic Information
Table 126. Livzon Pharmaceutical Group Second-Generation Antipsychotics Product Overview
Table 127. Livzon Pharmaceutical Group Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Livzon Pharmaceutical Group Business Overview
Table 129. Livzon Pharmaceutical Group Recent Developments
Table 130. Qilu Pharmaceutical Basic Information
Table 131. Qilu Pharmaceutical Second-Generation Antipsychotics Product Overview
Table 132. Qilu Pharmaceutical Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Qilu Pharmaceutical Business Overview
Table 134. Qilu Pharmaceutical Recent Developments
Table 135. CSPC Pharmaceutical Group Basic Information
Table 136. CSPC Pharmaceutical Group Second-Generation Antipsychotics Product Overview
Table 137. CSPC Pharmaceutical Group Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. CSPC Pharmaceutical Group Business Overview
Table 139. CSPC Pharmaceutical Group Recent Developments
Table 140. Chengdu Kanghong Pharmaceutical Basic Information
Table 141. Chengdu Kanghong Pharmaceutical Second-Generation Antipsychotics Product Overview
Table 142. Chengdu Kanghong Pharmaceutical Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Chengdu Kanghong Pharmaceutical Business Overview
Table 144. Chengdu Kanghong Pharmaceutical Recent Developments
Table 145. Hansoh Pharma Basic Information
Table 146. Hansoh Pharma Second-Generation Antipsychotics Product Overview
Table 147. Hansoh Pharma Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Hansoh Pharma Business Overview
Table 149. Hansoh Pharma Recent Developments
Table 150. Hisun Pharmaceutical Basic Information
Table 151. Hisun Pharmaceutical Second-Generation Antipsychotics Product Overview
Table 152. Hisun Pharmaceutical Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Hisun Pharmaceutical Business Overview
Table 154. Hisun Pharmaceutical Recent Developments
Table 155. Chia Tai Tianqing Pharmaceutical Basic Information
Table 156. Chia Tai Tianqing Pharmaceutical Second-Generation Antipsychotics Product Overview
Table 157. Chia Tai Tianqing Pharmaceutical Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Chia Tai Tianqing Pharmaceutical Business Overview
Table 159. Chia Tai Tianqing Pharmaceutical Recent Developments
Table 160. Yangtze River Pharmaceutical Group Basic Information
Table 161. Yangtze River Pharmaceutical Group Second-Generation Antipsychotics Product Overview
Table 162. Yangtze River Pharmaceutical Group Second-Generation Antipsychotics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Yangtze River Pharmaceutical Group Business Overview
Table 164. Yangtze River Pharmaceutical Group Recent Developments
Table 165. Global Second-Generation Antipsychotics Sales Forecast by Region (2026-2035) & (K MT)
Table 166. Global Second-Generation Antipsychotics Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Second-Generation Antipsychotics Sales Forecast by Country (2026-2035) & (K MT)
Table 168. North America Second-Generation Antipsychotics Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Second-Generation Antipsychotics Sales Forecast by Country (2026-2035) & (K MT)
Table 170. Europe Second-Generation Antipsychotics Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Second-Generation Antipsychotics Sales Forecast by Region (2026-2035) & (K MT)
Table 172. Asia Pacific Second-Generation Antipsychotics Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Second-Generation Antipsychotics Sales Forecast by Country (2026-2035) & (K MT)
Table 174. South America Second-Generation Antipsychotics Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Second-Generation Antipsychotics Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Second-Generation Antipsychotics Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Second-Generation Antipsychotics Sales Forecast by Type (2026-2035) & (K MT)
Table 178. Global Second-Generation Antipsychotics Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Second-Generation Antipsychotics Price Forecast by Type (2026-2035) & (USD/KG)
Table 180. Global Second-Generation Antipsychotics Sales (K MT) Forecast by Application (2026-2035)
Table 181. Global Second-Generation Antipsychotics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Second-Generation Antipsychotics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Second-Generation Antipsychotics Market Size (M USD), 2025-2035
Figure 5. Global Second-Generation Antipsychotics Market Size (M USD) (2020-2035)
Figure 6. Global Second-Generation Antipsychotics Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Second-Generation Antipsychotics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Second-Generation Antipsychotics Product Life Cycle
Figure 13. Second-Generation Antipsychotics Sales Share by Manufacturers in 2025
Figure 14. Global Second-Generation Antipsychotics Revenue Share by Manufacturers in 2025
Figure 15. Second-Generation Antipsychotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Second-Generation Antipsychotics Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Second-Generation Antipsychotics Revenue in 2025
Figure 18. Industry Chain Map of Second-Generation Antipsychotics
Figure 19. Global Second-Generation Antipsychotics Market PEST Analysis
Figure 20. Global Second-Generation Antipsychotics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Second-Generation Antipsychotics Market Share by Type
Figure 27. Sales Market Share of Second-Generation Antipsychotics by Type (2020-2025)
Figure 28. Sales Market Share of Second-Generation Antipsychotics by Type in 2025
Figure 29. Market Share of Second-Generation Antipsychotics by Type (2020-2025)
Figure 30. Market Share of Second-Generation Antipsychotics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Second-Generation Antipsychotics Market Share by Application
Figure 33. Global Second-Generation Antipsychotics Sales Market Share by Application (2020-2025)
Figure 34. Global Second-Generation Antipsychotics Sales Market Share by Application in 2025
Figure 35. Global Second-Generation Antipsychotics Market Share by Application (2020-2025)
Figure 36. Global Second-Generation Antipsychotics Market Share by Application in 2025
Figure 37. Global Second-Generation Antipsychotics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Second-Generation Antipsychotics Sales Market Share by Region (2020-2025)
Figure 39. Global Second-Generation Antipsychotics Market Size by Region (2020-2025)
Figure 40. North America Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Second-Generation Antipsychotics Sales Market Share by Country in 2024
Figure 43. North America Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Second-Generation Antipsychotics Market Size by Country in 2024
Figure 45. U.S. Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Second-Generation Antipsychotics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Second-Generation Antipsychotics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Second-Generation Antipsychotics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Second-Generation Antipsychotics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Second-Generation Antipsychotics Sales Market Share by Country in 2024
Figure 53. Europe Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Second-Generation Antipsychotics Market Size by Country in 2024
Figure 55. Germany Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Second-Generation Antipsychotics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Second-Generation Antipsychotics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Second-Generation Antipsychotics Market Size by Region in 2024
Figure 68. China Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Second-Generation Antipsychotics Sales and Growth Rate (K MT)
Figure 79. South America Second-Generation Antipsychotics Sales Market Share by Country in 2024
Figure 80. South America Second-Generation Antipsychotics Market Size and Growth Rate (M USD)
Figure 81. South America Second-Generation Antipsychotics Market Size by Country in 2024
Figure 82. Brazil Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Second-Generation Antipsychotics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Second-Generation Antipsychotics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Second-Generation Antipsychotics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Second-Generation Antipsychotics Market Size by Region in 2024
Figure 92. Saudi Arabia Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Second-Generation Antipsychotics Production Market Share by Region (2020-2025)
Figure 103. North America Second-Generation Antipsychotics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Second-Generation Antipsychotics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Second-Generation Antipsychotics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Second-Generation Antipsychotics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Second-Generation Antipsychotics Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Second-Generation Antipsychotics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Second-Generation Antipsychotics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Second-Generation Antipsychotics Market Share Forecast by Type (2026-2035)
Figure 111. Global Second-Generation Antipsychotics Sales Forecast by Application (2026-2035)
Figure 112. Global Second-Generation Antipsychotics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Second-Generation Antipsychotics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Second-Generation Antipsychotics Market Size (M USD), 2025-2035
Figure 5. Global Second-Generation Antipsychotics Market Size (M USD) (2020-2035)
Figure 6. Global Second-Generation Antipsychotics Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Second-Generation Antipsychotics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Second-Generation Antipsychotics Product Life Cycle
Figure 13. Second-Generation Antipsychotics Sales Share by Manufacturers in 2025
Figure 14. Global Second-Generation Antipsychotics Revenue Share by Manufacturers in 2025
Figure 15. Second-Generation Antipsychotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Second-Generation Antipsychotics Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Second-Generation Antipsychotics Revenue in 2025
Figure 18. Industry Chain Map of Second-Generation Antipsychotics
Figure 19. Global Second-Generation Antipsychotics Market PEST Analysis
Figure 20. Global Second-Generation Antipsychotics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Second-Generation Antipsychotics Market Share by Type
Figure 27. Sales Market Share of Second-Generation Antipsychotics by Type (2020-2025)
Figure 28. Sales Market Share of Second-Generation Antipsychotics by Type in 2025
Figure 29. Market Share of Second-Generation Antipsychotics by Type (2020-2025)
Figure 30. Market Share of Second-Generation Antipsychotics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Second-Generation Antipsychotics Market Share by Application
Figure 33. Global Second-Generation Antipsychotics Sales Market Share by Application (2020-2025)
Figure 34. Global Second-Generation Antipsychotics Sales Market Share by Application in 2025
Figure 35. Global Second-Generation Antipsychotics Market Share by Application (2020-2025)
Figure 36. Global Second-Generation Antipsychotics Market Share by Application in 2025
Figure 37. Global Second-Generation Antipsychotics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Second-Generation Antipsychotics Sales Market Share by Region (2020-2025)
Figure 39. Global Second-Generation Antipsychotics Market Size by Region (2020-2025)
Figure 40. North America Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Second-Generation Antipsychotics Sales Market Share by Country in 2024
Figure 43. North America Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Second-Generation Antipsychotics Market Size by Country in 2024
Figure 45. U.S. Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Second-Generation Antipsychotics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Second-Generation Antipsychotics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Second-Generation Antipsychotics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Second-Generation Antipsychotics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Second-Generation Antipsychotics Sales Market Share by Country in 2024
Figure 53. Europe Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Second-Generation Antipsychotics Market Size by Country in 2024
Figure 55. Germany Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Second-Generation Antipsychotics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Second-Generation Antipsychotics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Second-Generation Antipsychotics Market Size by Region in 2024
Figure 68. China Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Second-Generation Antipsychotics Sales and Growth Rate (K MT)
Figure 79. South America Second-Generation Antipsychotics Sales Market Share by Country in 2024
Figure 80. South America Second-Generation Antipsychotics Market Size and Growth Rate (M USD)
Figure 81. South America Second-Generation Antipsychotics Market Size by Country in 2024
Figure 82. Brazil Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Second-Generation Antipsychotics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Second-Generation Antipsychotics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Second-Generation Antipsychotics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Second-Generation Antipsychotics Market Size by Region in 2024
Figure 92. Saudi Arabia Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Second-Generation Antipsychotics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Second-Generation Antipsychotics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Second-Generation Antipsychotics Production Market Share by Region (2020-2025)
Figure 103. North America Second-Generation Antipsychotics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Second-Generation Antipsychotics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Second-Generation Antipsychotics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Second-Generation Antipsychotics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Second-Generation Antipsychotics Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Second-Generation Antipsychotics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Second-Generation Antipsychotics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Second-Generation Antipsychotics Market Share Forecast by Type (2026-2035)
Figure 111. Global Second-Generation Antipsychotics Sales Forecast by Application (2026-2035)
Figure 112. Global Second-Generation Antipsychotics Market Share Forecast by Application (2026-2035)
